CA - A Cancer Journal for Clinicians Q1 Unclaimed
CA: A Cancer Journal for Clinicians is a peer-reviewed journal published for the American Cancer Society by John Wiley & Sons, Inc. CA publishes comprehensive review articles of a multidisciplinary nature, which take into account the journal’s diverse readership of primary care physicians; medical, surgical, and radiation oncologists; nurses; and other health care and public health professionals. Articles published in CA provide up-to-date information on all aspects of cancer prevention, early detection, treatment of all forms, palliation, advocacy, quality of life, and more.
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy: Open Choice
Type of publications:
Publication frecuency: -


2500 €
Gold OA-
Green OA0 €
Non OAMetrics
88,192
SJR Impact factor156
H Index36
Total Docs (Last Year)129
Total Docs (3 years)2924
Total Refs22644
Total Cites (3 years)89
Citable Docs (3 years)255,73
Cites/Doc (2 years)81,22
Ref/DocAims and Scope
Other journals with similar parameters
Blood Q1
The Lancet Haematology Q1
Leukemia Q1
Journal of Hematology and Oncology Q1
Haematologica Q1
Best articles
A guide to cancer of the ear
View moreA Technique for Localizing Occult Breast Lesions
View moreA Tribute to Charles S. Cameron, MD, CA's Founding Editor
View moreAcupressure and Acupuncture for Side Effects of Radiotherapy
View moreAmerican Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: update 1997. American Cancer Society Detection and Treatment Advisory Group on Colorectal Cancer
View moreAmerican Cancer Society guidelines for the early detection of breast cancer: update 1997
View moreAmerican Cancer Society guidelines on screening for breast cancer: An overview
View moreBladder cancer, 1996
View moreBladder cancer: state-of-the-art care
View moreCancer and placebos
View moreCancer chemotherapeutic agents
View moreCancer chemotherapeutic and biologic agents
View moreChemotherapy-related nausea and vomiting: To the editor
View moreCommentary on "European Consensus Statement on Lung Cancer"
View moreConsensus statement from the American Cancer Society Workshop on neuroblastoma screening: Do benifit from mass screening for neuroblastoma?
View moreDaily aspirin may reduce mortality from prostate cancer with risk of high recurrence
View moreEditorial: Children and cancer
View moreEditorial: The environmental time bomb ...that never went off
View moreElectronic cigarettes did not help patients with cancer stop smoking
View moreElimination of cancer disparities via organizational transformation and community-driven approaches
View moreEnhancing global access to cancer medicines
View moreEstrogens and increased endometrial cancer: Fact or artifact?
View moreExamining the hypopharynx
View moreExemestane is effective for the chemoprevention of breast cancer
View more
Comments